MoneyWorks4Me

Aurobindo Pharma informs about disclosure

02 May 2024 Evaluate

With reference to its letter dated February 5, 2024, informing about disposal of business assets of Eugia US Manufacturing LLC, a wholly owned step- down subsidiary of the Company. In this regard, Aurobindo Pharma has informed that the aforementioned disposal of business assets has been completed on May 1, 2024.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..